William Gewin
Pulmonary Disease · Mobile, ALNPI 1386692267
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 174 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,426 and has fallen 79.3% since, to $295 in 2021. That places this record below the midpoint for pulmonary disease clinicians in AL, where the typical reported total is $3,082.
Across 174 payments — averaging $15.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$592
- Actelion Pharmaceuticals US, Inc.$422
- Grifols USA, LLC$277
- AstraZeneca$263
- Boehringer Ingelheim$242
- Electromed, Inc.$184
- plus $656 from 15 others
What the payments were for
- Food & beverage$2,636100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 52 | $592 |
| Actelion Pharmaceuticals US, Inc. | 22 | $422 |
| Grifols USA, LLC | 11 | $277 |
| AstraZeneca | 20 | $263 |
| Boehringer Ingelheim | 13 | $242 |
| Electromed, Inc. | 16 | $184 |
| Philips North America LLC | 9 | $136 |
| Genentech USA, Inc. | 5 | $83 |
| Sunovion Pharmaceuticals Inc. | 6 | $67 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Sanofi | 3 | $61 |
| United Therapeutics Corporation | 2 | $46 |
| Mallinckrodt Hospital Products Inc. | 2 | $46 |
| Mylan Specialty L.p. | 2 | $34 |
| Pfizer | 2 | $31 |
| Harmony Biosciences LLC | 1 | $21 |
| Merck | 1 | $17 |
| Novartis | 1 | $17 |
| Johnson & Johnson | 1 | $13 |
| Circassia Inc. | 1 | $11 |
| Novo Nordisk | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,636 in reported general payments places this provider in the 45th percentile of 215 pulmonary disease providers in Alabama.
Other pulmonary disease in Mobile
- Adrian DivittorioMobile$100K
- Peter LutzMobile$63K
- Virginia RadcliffMobile$23K
- Johnson HaynesMobile$21K
- Cynthia CrowderMobile$20K
- Philip AlmaloufMobile$14K
- Campbell SindelMobile$14K
- Chibuzo OdigweMobile$14K
- Caesar AgaganMobile$11K
- James DeanMobile$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.